ALS
Clinical trials for ALS explained in plain language.
Never miss a new study
Get alerted when new ALS trials appear
Sign up with your email to follow new studies for ALS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for ALS patients: experimental drug CNM-Au8 now available through expanded access
Disease control TEMPORARILY_NOT_AVAILABLEThis program provides early access to an experimental drug called CNM-Au8 for people with amyotrophic lateral sclerosis (ALS), a progressive nerve disease. Participants must be 18 or older and have a confirmed ALS diagnosis. The goal is to offer treatment to those who cannot join…
Matched conditions: ALS
Sponsor: Clene Nanomedicine • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Could your own fat cells fight ALS? new trial tests safety and effectiveness
Disease control OngoingThis study tests a new treatment for ALS (Lou Gehrig's disease) using stem cells taken from the patient's own belly fat. The cells are injected into the fluid around the spine every 3 months for a year. The goal is to see if this treatment is safe and can slow down the disease. A…
Matched conditions: ALS
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Breath of hope: drug and oxygen combo tested for ALS breathing
Symptom relief OngoingThis study tests whether a drug called istradefylline, combined with short periods of breathing low-oxygen air (acute intermittent hypoxia), can improve breathing in people with ALS. About 40 adults with ALS and healthy volunteers will take part. The goal is to see if this combin…
Matched conditions: ALS
Phase: PHASE1, PHASE2 • Sponsor: University of Florida • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC